Application of fluorescence microscopy for investigation of cellular distribution of dinuclear platinum anticancer drugs

Journal of Medicinal Chemistry

Volumn 48, Issue 16, 2005, Pages 5191-5202

  Kalayda, Ganna V ^a   Zhang, Guofang ^a   Abraham, Tsion ^b   Tanke, Hans J ^b   Reedijk, Jan ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; [BIS [[1 (2,4 DINITROPHENYLHEXANOIC AMINOMETHYLENE) 1,2 ETHYLENEDIAMINE]CHLOROPLATINUM](MU 1,6 HEXANEDIAMINE)]CHLORIDE; [BIS [[1 (5 CARBOXYFLUORESCEIN DIACETATE AMINOMETHYL) 1,2 ETHYLENEDIAMINE]CHLOROPLATINUM](MU 1,6 HEXANEDIAMINE)]CHLORIDE; [BIS [[1 (6 CARBOXYFLUORESCEIN DIACETATE AMINOMETHYL) 1,2 ETHYLENEDIAMINE]CHLOROPLATINUM](MU 1,6 HEXANEDIAMINE)]CHLORIDE; HAPTEN; PLATINUM COMPLEX; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; DRUG DESIGN; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DINITROBENZENES; DRUG RESISTANCE, NEOPLASM; FLUORESCEINS; GUANINE; HUMANS; MICROSCOPY, FLUORESCENCE; ORGANOPLATINUM COMPOUNDS;

EID: 23444457798     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050216h     Document Type: Article

References (52)

1. Farrell, N. Structurally novel platinum-based drugs in the clinic. Toward a new paradigm. J. Inorg. Biochem. 1999, 74, 23-23.
2. Komeda, S.; Kalayda, G. V.; Lutz, M.; Spek, A. L.; Yamanaka, Y.; Sato, T.; Chikuma, M.; Reedijk, J. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin. J. Med. Chem. 2003, 46, 1210-1219.
3. Reedijk, J. New clues for platinum antitumor chemistry: Kinetically controlled metal binding to DNA. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 3611-3616.
4. Wong, E.; Giandomenico, C. M. Current status of platinum-based antitumor drugs. Chem. Rev. 1999, 99, 2451-2466.
5. Farrell, N.; Qu, Y.; Bierbach, U.; Valsecchi, M.; Menta, E. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug; Wiley VCH: Weinheim, Germany, 1999; pp 479-496.
6. Komeda, S.; Lutz, M.; Spek, A. L.; Chikuma, M.; Reedijk, J. New antitumor-active azole-bridged dinuclear platinum(II) complexes: Synthesis, characterization, crystal structures, and cytotoxic studies. Inorg. Chem. 2000, 39, 4230-4236.
7. Wheate, N. J.; Collins, J. G. Multi-nuclear platinum complexes as anti-cancer drugs. Coord. Chem. Rev. 2003, 241, 133-145.
8. Di Blasi, P.; Bernareggi, A.; Beggiolin, G.; Piazzoni, L.; Menta, E.; Formento, M. L. Cytotoxicity, cellular uptake and DNA binding of the novel trinuclear platinum complex BBR 3464 in sensitive and cisplatin resistant murine leukemia cells. Anticancer Res. 1998, 18, 3113-3117.
9. Manzotti, C.; Pratesi, G.; Menta, E.; Di Domenico, R.; Cavalletti, E.; Fiebig, H. H.; Kelland, L. R.; Farrell, N.; Polizzi, D.; Supino, R.; Pezzoni, G.; Zunino, F. BBR 3464: A novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin. Clin. Cancer Res. 2000, 6, 2626-2634.
10. Rauter, H.; DiDomenico, R.; Menta, E.; Oliva, A.; Qu, Y.; Farrell, N. Selective platination of biologically relevant polyamines. Linear coordinating spermidine and spermine as amplifying linkers in dinuclear platinum complexes. Inorg. Chem. 1997,36, 3919-3927.
11. Brabec, V.; Kasparkova, J.; Vrana, O.; Novakova, O.; Cox, J. W.; Qu, Y.; Farrell, N. DNA modifications by a novel bifunctional trinuclear platinum Phase I anticancer agent. Biochemistry 1999, 38, 6781-6790.
12. Mellish, K. J.; Qu, Y.; Scarsdale, N.; Farrell, N. Effect of geometric isomerism in dinuclear platinum antitumour complexes on the rate of formation and structure of intrastrand adducts with oligonucleotides. Nucleic Acids Res. 1997, 25, 1265-1271.
13. Johnson, A.; Qu, Y.; Van Houten, B.; Farrell, N. B-Z DNA conformational changes induced by a family of dinuclear bis-complexes. Nucleic Acids Res. 1992, 20, 1697-1703.
14. Andrews, P.; Howell, S. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 1990, 2, 35-43.
15. Reedijk, J. Why does cisplatin reach guanine-N7 with competing S-donor ligands available in the cell? Chem. Rev. 1999, 99, 2499-2510.
16. Fuertes, M. A.; Alonso, C.; Perez, J. M. Biochemical modulation of cisplatin mechanisms of action: Enhancement of antitumor activity and circumvention of drug resistance. Chem. Rev. 2003, 103, 645-662.
17. Perez, R. P. Cellular and molecular determinants of cisplatin resistance. Eur. J. Cancer 1998, 34, 1535-1542.
18. Molenaar, C.; Teuben, J. M.; Heetebrij, R. J.; Tanke, H. J.; Reedijk, J. New insights in the cellular processing of platinum antitumor compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy. J. Biol. Inorg. Chem. 2000, 5, 655-665.
19. Jansen, B. A. J.; Wielaard, P.; Kalayda, G. V.; Ferrari, M.; Molenaar, C.; Tanke, H. J.; Brouwer, J.; Reedijk, J. Dinuclear platinum complexes with N,N′-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part I. Synthesis, cytotoxicity, and cellular studies in A2780 human ovarian carcinoma cells. J. Biol. Inorg. Chem. 2004, 9, 403-413.
20. Kalayda, G. V.; Jansen, B. A. J.; Molenaar, C.; Wielaard, P.; Tanke, H. J.; Reedijk, J. Dinuclear platinum complexes with N,N′-bis(aminoalkyl)-1, 4-diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: new insights into the mechanism of resistance. J. Biol. Inorg. Chem. 2004, 9, 414-422.
21. Kalayda, G. V.; Jansen, B. A. J.; Wielaard, P.; Tanke, H. J.; Reedijk, J. Dinuclear platinum anticancer complexes with fluorescent N,N′- bis(ammoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin resistant cell lines reflects the differences in their resistance profiles. J. Biol. Inorg. Chem. 2005, 10, 305-315.
22. Arancia, G.; Calcabrini, A.; Meschini, S.; Molinari, A. Intracellular distribution of anthracyclines in drug resistant cells. Cytotechnology 1998, 27, 95-111.
23. Hindenburg, A. A.; Gervasoni, J. E., Jr.; Krishna, S.; Stewart, V. J.; Rosado, M.; Lutzky, J.; Bhalla, K.; Baker, M. A.; Taub, R. N. Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and resistant HL-60 cells. Cancer Res. 1989, 49, 4607-4614.
24. Larsen, A. K.; Escargueil, A. E.; Skladanowski, A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol. Ther. 2000, 85, 217-229.
25. Meistermann, I.; Kalayda, G. V.; Hotze, A. C. G.; Reedijk, J. Preparation of a new ruthenium(II) building block for the synthesis of mixed-metal complexes. Tetrahedron Lett. 2004, 45, 2593-2596.
26. Yang, D. Z.; van Boom, S. S. G. E.; Reedijk, J.; van Boom, J. H.; Wang, A. H. J. Structure and isomerization of an intrastrand cisplatin-cross-linked octamer DNA duplex by NMR analysis. Biochemistry 1995, 34, 12912-12920.
27. Reedijk, J. Improved understanding in platinum antitumour chemistry. Chem. Commun. 1996, 801-806.
28. Perego, P.; Caserini, C.; Gatti, L.; Carenini, N.; Romanelli, S.; Supino, R.; Colangelo, D.; Viano, I.; Leone, R.; Spinelli, S.; Pezzoni, G.; Manzotti, C.; Farrell, N.; Zunino, F. A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system. Mol. Pharmacol. 1999, 55, 528-534.
29. Declerck, L. S.; Bridts, C. H.; Mertens, A. M.; Moens, M. M.; Stevens, W. J. Use of fluorescent dyes in the determination of adherence of human leukocytes to endothelial cells and the effect of fluorochromes on cellular function. J. Immunol. Methods 1994, 172, 115-124.
30. Davenpeck, K. L.; Chrest, F. J.; Sterbinsky, S. A.; Bickel, C. A.; Bochner, B. S. Carboxyfluorescein diacetate labeling does not affect adhesion molecule expression or function in human neutrophils or eosinophils. J. Immunol. Methods 1995, 188, 79-89.
31. Perego, P.; Gatti, L.; Caserini, C.; Supino, R.; Colangelo, D.; Leone, R.; Spinelli, S.; Farrell, N.; Zunino, F. The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells. J. Inorg. Biochem. 1999, 77, 59-64.
32. Gong, Y. P.; Duvvuri, M.; Krise, J. P. Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multi-drug resistant human leukemic cell line HL-60. J. Biol. Chem. 2003, 278, 50234-50239.
33. Bour-Dill, C.; Gramain, M. P.; Merlin, J. L.; Marchai, S.; Guillemin, F. Determination of intracellular organelles implicated in daunorubicin cytoplasmic sequestration in multidrug-resistant MCF-7 cells using fluorescence microscopy image analysis. Cytometry 2000, 39, 16-25.
34. Meijer, C.; de Vries, E. G. E.; Dam, W. A.; Wilkinson, M. H. F.; Hollema, H.; Hoekstra, H. J.; Mulder, N. H. Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy. Br. J. Cancer 1997, 76, 290-298.
35. Hall, M. D.; Dillon, C. T.; Zhang, M.; Beale, P.; Cai, Z.; Lai, B.; Stampfl, A. P. J.; Hambley, T. W. The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumor complexes in cancer cells. J. Biol. Inorg. Chem. 2003, 8, 726-732.
36. Jansen, B. A. J.; Brouwer, J.; Reedijk, J. Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs. J. Inorg. Biochem. 2002, 89, 197-202.
37. 195Pt) NMR spectroscopy. Inorg. Chem. 2003, 42, 5498-5506.
38. Roberts, J. D.; Peroutka, J.; Beggiolin, G.; Manzotti, C.; Piazzoni, L.; Farrell, N. Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines. J. Inorg. Biochem. 1999, 77, 47-50.
39. Center, M. S. Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug. Cytotechnology 1993, 12, 109-125.
40. Molinari, A.; Cianfriglia, M.; Meschini, S.; Calcabrini, A.; Arancia, G. P-glycoprotein expression in the Golgi apparatus of multidrug-resistant cells. Int. J. Cancer 1994, 59, 789-795.
41. Aggarwal, S. K. A Histochemical approach to the mechanism of action of cisplatin and its analogs. J. Histochem. Cytochem. 1993, 41, 1053-1073.
42. Edwards, P. G.; Kendall, M. D.; Morris, I. W. Effect of a platinum chemotherapy drug on intracellular elements during the cell cycle, using X-ray microanalysis. Scanning Microsc. 1991, 5, 797-810.
43. Olivero, O. A.; Semino, C.; Kassim, A.; Lopezlarraza, D. M.; Poirier, M. C. Preferential binding of cisplatin to mitochondrial DNA of Chinese hamster ovary. Mutat. Res. Lett. 1995, 346, 221-230.
44. Meijer, C.; van Luyn, M. J. A.; Nienhuis, E. F.; Blom, L.; Mulder, N. H.; de Vries, E. G. E. Ultrastructural morphology and localisation of cisplatin-induced platinum-DNA adducts in a cisplatin-sensitive and -resistant human small cell lung cancer cell line using electron microscopy. Biochem. Pharmacol. 2001, 61, 573-578.
45. Murata, T.; Hibasami, H.; Maekawa, S.; Tagawa, T.; Nakashima, K. Preferential binding of cisplatin to mitochondrial DNA and suppression of ATP generation in human malignant melanoma cells. Biochem. Int. 1990, 20, 949-955.
46. Giurgiovich, A. J.; Diwan, B. A.; Olivero, O. A.; Anderson, L. M.; Rice, J. M.; Poirier, M. C. Elevated mitochondrial cisplatin-DNA adduct levels in rat tissues after transplacental cisplatin exposure. Carcinogenesis 1997, 18, 93-96.
47. Kaufman, G. B.; Cowan, D. O. Inorganic Synthesis; McGraw-Hill Book Company, Inc.: New York, 1963; pp 242-243.
48. Qu, Y.; Farrell, N. Effect of diamine linker on the chemistry of bis(platinum) complexes - a comparison of the aqueous solution behavior of 1,4-butanediamine and 2,5-dimethyl-2,5-hexanediamine complexes. J. Inorg. Biochem. 1990, 40, 255-264.
49. Qu, Y.; Farrell, N. The product of the reaction of trans- diamminedichloroplatinum (II) with diamines is dependent on chain length - example of a bridging ethylenediamine and formation of a novel trans-chelated structure with 1,5-pentanediamine. Inorg. Chem. 1992, 31, 930-932.
50. Farrell, N.; Appleton, T. G.; Qu, Y.; Roberts, J. D.; Fontes, A. P. S.; Skov, K. A.; Wu, P.; Zou, Y. Effects of geometric isomerism and ligand substitution in bifunctional dinuclear platinum complexes on binding properties and conformational changes in DNA. Biochemistry 1995, 34, 15480-15486.
51. Martin, R. B. Deuterated water effects on acid ionization constants. Science 1963, 139, 1198.
52. Alley, M. C.; Scudiero, D. A.; Monks, A.; Hursey, M. L.; Czerwinski, M. J.; Fine, D. L.; Abbott, B. J.; Mayo, J. G.; Shoemaker, R. H.; Boyd, M. R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988, 48, 589-601.